Catalyst Wire Dossier Catalyst Wire Dossier

Intratumor CpG-ODN injection

CpG oligodeoxynucleotide
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Intratumor CpG-ODN injection, covering 2024-06-26 to 2024-06-26. Get the full timeline:

Most recent: Clinical Trial Update: Intratumor CpG-ODN Injection Boosters Immune Killing Against in Situ Tumor Antigen Release for Advanced Solid Tumors [Phase 1]

See pricing